|
| Status |
Public on Dec 01, 2017 |
| Title |
Inhibition of TGFβRI as a therapy for GATA4 deficient lung cancers |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Jul 29, 2016 |
| Last update date |
May 15, 2019 |
| Contact name |
huanwei huang |
| E-mail(s) |
hhw2436@gmail.com
|
| Organization name |
NIBS
|
| Street address |
7 Science Park Rd., ZGC life science park
|
| City |
Beijing |
| ZIP/Postal code |
102206 |
| Country |
China |
| |
|
| Platforms (1) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
| Samples (6)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE85001 |
Inhibition of TGFβRI as a therapy for GATA4 deficient lung cancers [RNA-seq] |
| GSE85002 |
Inhibition of TGFβRI as a therapy for GATA4 deficient lung cancers [ChIP-seq] |
|
| Relations |
| BioProject |
PRJNA335852 |
Less...
More...